The post ETHZilla Rebrands With Ethereum Treasury Strategy, Begins Trading on Nasdaq appeared on BitcoinEthereumNews.com. Former biotech firm pivots to crypto accumulation vehicle with $419M in ETH holdings. ETHZilla Corporation, formerly 180 Life Sciences Corp., on Monday, Aug. 18, launched its new brand and Ethereum (ETH) treasury strategy – marking a pivot from biotechnology to Ether accumulation – while beginning trading on the Nasdaq under the new ticker ETHZ. The Palm Beach–based company disclosed that it has acquired 94,675 ETH at an average price of $3,902.20 – worth about $411 million at ETH’s current price of $4,342 – alongside $187 million in cash equivalents, according to a press release viewed by The Defiant. The ETHZ stock closed at $7.41, up 5.26% on the day. The rebrand comes amid accelerating on-chain treasury activity as more traditional finance (TradFi) firms increasingly accumulate digital assets as part of their treasury strategies. Firms are especially looking at ETH to bolster their treasuries because of its yield opportunities over Bitcoin (BTC). ETHZilla’s rebrand follows a $565 million fundraising effort with participation from over 60 institutional and crypto-native investors such as Electric Capital, Polychain, and GSR. Several prominent crypto founders are also investors, including Sreeram Kannan, founder of Eigenlayer; Mike Silagadze, founder of Ether.fi; Danny Ryan, Grant Hummer, and Vivek Raman, co-founders of Etherealize; and Tarun Chitra, founder of Gauntlet. “Today, we are embracing our identity as ETHZilla and our commitment to developing a market-leading strategy that seeks to bring the value of Ethereum to investors in the public markets,” said McAndrew Rudisill, Executive Chairman. “We are launching this new brand and our new treasury strategy with significant interest from the market and valuable partnerships with prominent Ethereum ecosystem founders and leaders.” The company said Electric Capital will serve as its external asset manager with plans to deploy a yield-generating strategy aimed at outperforming traditional ETH staking, as well as a… The post ETHZilla Rebrands With Ethereum Treasury Strategy, Begins Trading on Nasdaq appeared on BitcoinEthereumNews.com. Former biotech firm pivots to crypto accumulation vehicle with $419M in ETH holdings. ETHZilla Corporation, formerly 180 Life Sciences Corp., on Monday, Aug. 18, launched its new brand and Ethereum (ETH) treasury strategy – marking a pivot from biotechnology to Ether accumulation – while beginning trading on the Nasdaq under the new ticker ETHZ. The Palm Beach–based company disclosed that it has acquired 94,675 ETH at an average price of $3,902.20 – worth about $411 million at ETH’s current price of $4,342 – alongside $187 million in cash equivalents, according to a press release viewed by The Defiant. The ETHZ stock closed at $7.41, up 5.26% on the day. The rebrand comes amid accelerating on-chain treasury activity as more traditional finance (TradFi) firms increasingly accumulate digital assets as part of their treasury strategies. Firms are especially looking at ETH to bolster their treasuries because of its yield opportunities over Bitcoin (BTC). ETHZilla’s rebrand follows a $565 million fundraising effort with participation from over 60 institutional and crypto-native investors such as Electric Capital, Polychain, and GSR. Several prominent crypto founders are also investors, including Sreeram Kannan, founder of Eigenlayer; Mike Silagadze, founder of Ether.fi; Danny Ryan, Grant Hummer, and Vivek Raman, co-founders of Etherealize; and Tarun Chitra, founder of Gauntlet. “Today, we are embracing our identity as ETHZilla and our commitment to developing a market-leading strategy that seeks to bring the value of Ethereum to investors in the public markets,” said McAndrew Rudisill, Executive Chairman. “We are launching this new brand and our new treasury strategy with significant interest from the market and valuable partnerships with prominent Ethereum ecosystem founders and leaders.” The company said Electric Capital will serve as its external asset manager with plans to deploy a yield-generating strategy aimed at outperforming traditional ETH staking, as well as a…

ETHZilla Rebrands With Ethereum Treasury Strategy, Begins Trading on Nasdaq

Former biotech firm pivots to crypto accumulation vehicle with $419M in ETH holdings.

ETHZilla Corporation, formerly 180 Life Sciences Corp., on Monday, Aug. 18, launched its new brand and Ethereum (ETH) treasury strategy – marking a pivot from biotechnology to Ether accumulation – while beginning trading on the Nasdaq under the new ticker ETHZ.

The Palm Beach–based company disclosed that it has acquired 94,675 ETH at an average price of $3,902.20 – worth about $411 million at ETH’s current price of $4,342 – alongside $187 million in cash equivalents, according to a press release viewed by The Defiant. The ETHZ stock closed at $7.41, up 5.26% on the day.

The rebrand comes amid accelerating on-chain treasury activity as more traditional finance (TradFi) firms increasingly accumulate digital assets as part of their treasury strategies. Firms are especially looking at ETH to bolster their treasuries because of its yield opportunities over Bitcoin (BTC).

ETHZilla’s rebrand follows a $565 million fundraising effort with participation from over 60 institutional and crypto-native investors such as Electric Capital, Polychain, and GSR. Several prominent crypto founders are also investors, including Sreeram Kannan, founder of Eigenlayer; Mike Silagadze, founder of Ether.fi; Danny Ryan, Grant Hummer, and Vivek Raman, co-founders of Etherealize; and Tarun Chitra, founder of Gauntlet.

“Today, we are embracing our identity as ETHZilla and our commitment to developing a market-leading strategy that seeks to bring the value of Ethereum to investors in the public markets,” said McAndrew Rudisill, Executive Chairman. “We are launching this new brand and our new treasury strategy with significant interest from the market and valuable partnerships with prominent Ethereum ecosystem founders and leaders.”

The company said Electric Capital will serve as its external asset manager with plans to deploy a yield-generating strategy aimed at outperforming traditional ETH staking, as well as a mix of staking, lending, liquidity provisioning, and private agreements.

Recently, staked ETH hit a new all-time high, signaling growing long-term confidence in the network. As of this week, more than 35.7 million ETH – worth nearly $154 billion – is locked in Ethereum’s Proof-of-Stake system, representing about 30% of the total supply, according to BeaconChain. However, it’s worth noting that a significant number of stakers are also queuing to exit as ETH trades near its all-time high.

Source: https://thedefiant.io/news/tradfi-and-fintech/ethzilla-rebrands-with-ethereum-treasury-strategy-begins-trading-on-nasdaq

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$66,840.23
$66,840.23$66,840.23
+4.47%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
Federal Reserve Lowers Interest Rates Again

Federal Reserve Lowers Interest Rates Again

The Federal Reserve has made the decision to lower interest rates by 25 basis points, signaling the possibility of further reductions later this year. This move comes as Fed officials appear divided on the future rate path, a divergence not seen in prior economic cycles.Continue Reading:Federal Reserve Lowers Interest Rates Again
Share
Coinstats2025/09/18 02:38
Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Patent strengthens Niagen Bioscience’s intellectual property moat in fast-growing NAD+-boosting IV and injectable delivery formats, supporting commercial expansion
Share
AI Journal2026/02/25 21:36